NHS Diagnostic Processes: Technological Innovation

My Department is working incredibly closely with the Department of Health and Social Care, and the Secretary of State for Health and Social Care and I are joined at the hip on these issues. That includes unprecedented investment in research and development to understand how better to diagnose disease. There is co-investment in initiatives such as health innovation networks, which have enabled 1.2 million patients to access proven innovations, and the digital centre of Government, which we have created, is partnering closely with the NHS to improve the deployment and innovation of technology.

I thank the Secretary of State for his response. My constituency of Cannock Chase has wide health inequalities, and particularly high levels of respiratory illness and bladder and brain cancer. In some parts of the country, NHS trusts are rapidly speeding up diagnostic waiting times by using highly accurate AI models, with the results checked by human clinicians. Will the Secretary of State confirm that the Government are supporting such safe tech innovations to help fulfil our mission to build an NHS fit for the future?

I can indeed commit to that. The Government see the embrace of proven technologies and innovation as fundamental to the future survival of the NHS. I was incredibly happy to see that last autumn, the Royal Wolverhampton NHS trust began enrolling patients in a global-first trial of completely personalised cancer vaccines, as part of a £1 billion investment negotiated by my Department. That shows the way forward and how co-operation between Departments will deliver for patients and public service users across the country.

Early diagnosis saves lives. Randox in my constituency runs a number of NHS health checks from the Isle of Wight through to Lanarkshire. Will the Secretary of State encourage greater use of those checks, and will he visit Randox with me to see how we can further advance that technology?

I confirm that I have been working with the Health Secretary—indeed, we recently visited St Tommy’s across the road from here to see how new technology is being used in diagnostics. It is increasing the number of scans and improving the quality of those scans to diagnose disease early and prevent it from having the worst outcome. That is being rolled out across the country, and I am working closely with the Health Secretary to ensure that such innovations are put to good use for the country.

I call the Chair of the Science, Innovation and Technology Committee.

Last month, the Select Committee brought festive cheer by hearing how British science is advancing the eradication of diseases such as cervical cancer, HIV/AIDS and malaria, through innovative and exciting new treatments and diagnostics. We also heard about the challenges of driving innovation through the NHS. Newcastle company AMLo Biosciences said that adoption is much quicker in the US, and others criticised bureaucratic procurement processes and a culture of inertia. Successive Governments have struggled with this challenge, so what specific steps is the Secretary of State taking with the Health Secretary to ensure that British patients benefit from innovation?

I am grateful for that question and for the work that my hon. Friend’s Committee is doing to highlight the incredibly important challenge that we face as a Government and a country. For the first time, the Health Secretary has adopted the spreading of innovation through the NHS as a personal mission as part of the role of the Secretary of State, and we co-chair the Office for Life Sciences. Together, our two Departments are not only seeking to harness the power of technology, but working together, under the leadership of the Health Secretary, to drive that innovation. Such innovation cannot be locked up in one innovative health trust; it must be put to use across the NHS for every patient from every part of the United Kingdom.

What progress has been made on using AI algorithms to analyse medical images of things such as tumours, fractures or other medical conditions? That was a pithy question, I think, Mr Speaker.

I am grateful for the hon. Member’s question. I have visited Huddersfield hospital, which is one of the first hospitals to fully integrate AI in its radiotherapy and scanning work. Having stood there and seen its power for early diagnosis through its ability to detect patterns at an incredibly early stage, I am left in no doubt that, had my mother been scanned at that hospital, she would still be alive today. She was scanned three times, but the progress of her lung cancer was missed and she died several weeks after collapsing, with it not having been detected. This is the power of technology. AI is a human power that will transform lives and we are determined to ensure—

Order. Secretary of State, please. I am sure you want me to get to the other questions. I call the Liberal Democrat spokesperson.

Many of the companies I have spoken to who are supporting technological innovation in the NHS and beyond talk about their frustration at the comparative difficulty of getting funding in the UK and say that the British Business Bank could do much more to de-risk investment and unlock innovation. What are the Government doing to reform funding and provide an oasis in what has become known as the funding valley of death?

The first thing that we have done is increase to record levels overall the Government’s investment in R&D. Pioneering work is also going on through Innovate UK, the Advanced Research and Invention Agency and the different funding bodies that are available to take different levels of risk when it comes to supporting, creating and upscaling innovation. The work that the Chancellor is doing to reform our pension system will unlock capital, because fundamentally we must get more domestic capital into the venture capital community so that we can get domestic innovation supported by domestic capital to upscale and solve the challenges that the hon. Member talked about.